Hartmann´s Solution Fresenius Kabi (Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Sodium Lactate (As 50% Solution))

Hartmann's Solution is indicated for situations where rapid fluid and electrolyte replacement is required, such as during surgery or acute dehydration.

• Fluid resuscitation in patients with hypovolemia, hemorrhagic shock, or significant blood loss.
• Electrolyte replacement to correct deficits of potassium, sodium, calcium, and lactate in acute settings.
• Peri‑operative fluid management to maintain intravascular volume and hemodynamic stability during surgery.
• Treatment of dehydration resulting from gastrointestinal losses, burns, or excessive sweating.
• Support for patients on parenteral nutrition who require a balanced electrolyte composition.

Like all intravenous fluids, Hartmann's Solution may be associated with adverse reactions ranging from mild infusion‑site symptoms to rare but serious metabolic disturbances.

Common

• Mild pain, burning, or irritation at the infusion site.
• Transient increase in serum sodium or potassium levels.
• Mild metabolic alkalosis due to lactate metabolism.
• Slight elevation of blood calcium concentration.
• Mild headache or dizziness during rapid infusion.
• Temporary decrease in blood pressure (hypotension) if administered too quickly.

Serious

• Hypernatremia or severe electrolyte imbalance.
• Fluid overload leading to pulmonary edema.
• Severe allergic or anaphylactic reaction.
• Metabolic acidosis if lactate metabolism is impaired.
• Severe hyperkalemia leading to cardiac arrhythmias.
• Acute renal failure secondary to volume overload.

Clinicians should evaluate patient-specific factors before administering Hartmann's Solution to minimize risks and ensure appropriate fluid therapy.

• Assess baseline electrolyte levels and renal function prior to infusion.
• Adjust infusion rate in patients at risk for fluid overload or heart failure.
• Use caution in individuals with severe liver disease due to altered lactate metabolism.
• Avoid rapid administration in neonates and small children without weight‑based dosing.
• Monitor blood pressure and cardiac rhythm during and after infusion.
• Re‑evaluate serum electrolytes regularly during prolonged therapy.

Hartmann's Solution may interact with other intravenous or oral agents that affect fluid balance, electrolytes, or acid‑base status.

Avoid

• Concurrent administration of hypertonic saline solutions, which can cause severe hypernatremia.
• Simultaneous infusion of calcium‑containing medications through the same line without proper flushing.
• Co‑administration with bicarbonate solutions, which may precipitate calcium carbonate and obstruct lines.

Use with caution

• Loop diuretics, as they may exacerbate electrolyte shifts.
• ACE inhibitors or ARBs, which can increase the risk of hyperkalemia.
• Blood products, requiring careful monitoring of calcium and potassium levels.
• Insulin therapy, which can alter potassium distribution when combined with the solution.
• Vasopressors, because rapid volume expansion can potentiate blood pressure changes.